Paola Cappellano

Paola Cappellano

Auto-generated profile, based on publicly available information

Paola Cappellano

University Hospital, Federal University of São Paulo (UNIFESP), São Paulo

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2004 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
CVClaudio Viscoli
Claudio Viscoli
MMMarco Machetti
Marco Machetti
PCPaola Cappellano
Paola Cappellano
BBBarbara Bucci
Barbara Bucci
PBPaolo Bruzzi
Paolo Bruzzi
ABAndrea Bacigalupo
Andrea Bacigalupo
At the bone marrow transplantation center of the San Martino Hospital (Genoa), we observed an increase in the rate of patients with positive Platelia

1 June 2014 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
MNMarcio Nucci
Marcio Nucci
KMK.A. Marr
K.A. Marr
MVM.J.G.T. Vehreschild
M.J.G.T. Vehreschild
CSC.A. de Souza
C.A. de Souza
EVE. Velasco
E. Velasco
EAE. Anaissie
E. Anaissie
Invasive fusariosis (IF) is a leading mycosis affecting immunocompromised patients [1 x 1 Nucci, M and Anaissie, E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007; 20: 695–704 Crossref | PubMed | Scopus (454) | Google Scholar See all References ]. The disease is usually invasive and disseminated, affecting mostly neutropenic patients with acute leukaemia [2 x 2 Nucci, M, Anaissie, EJ, Queiroz-Telles, F et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003; 98: 315–319 Crossref | PubMed | Scopus (169) | Google Scholar See all References ] or patients with severe T-cell immunodeficiency, especially haematopoietic cell transplant recipients receiving corticosteroids for the treatment of severe graft-versus-host disease (GVHD) [3 x 3 Nucci, M, Marr, KA, Queiroz-Telles, F et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2004; 38: 1237–1242 Crossref | PubMed | Scopus (208) | Google Scholar See all References ]. Most infections in humans are caused by Fusarium solani species complex and Fusarium oxysporum species complex [1 x 1 Nucci, M and Anaissie, E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007; 20: 695–704 Crossref | PubMed | Scopus (454) | Google Scholar See all References ].

28 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MNMarcio Nucci
Marcio Nucci
FCFabianne Carlesse
Fabianne Carlesse
PCPaola Cappellano
Paola Cappellano
AVAndrea G. Varon
Andrea G. Varon
ASAdriana Seber
Adriana Seber
Arnaldo L. ColomboArnaldo L. Colombo
Arnaldo L. Colombo
Cross-reactivity of Fusarium species with serum galactomannan antigen (GMI) test has been observed. We sought to evaluate if GMI could help to early diagnose invasive fusariosis and to monitor treatment response. We reviewed the records of all patients with invasive fusariosis between 2008 and 2012 in three Brazilian hospitals. We selected patients who had at least 1 GMI test within 2 days before or after the date of the first clinical manifestation of fusariosis, and analyzed the temporal relationship between the first positive GMI test and the date of the diagnosis of invasive fusariosis, and the kinetics of GMI in relation to patients' response to treatment. We also selected 18 controls to determine the sensitivity and specificity of the test. Among 18 patients, 15 (83%) had at least one positive GMI (median 4, range 1–15). The sensitivity and specificity of was 83% and 67%, respectively. GMI was positive before the diagnosis of invasive fusariosis in 11 of the 15 cases (73%), at a median of 10 days (range 3–39), and after the diagnosis in 4 cases. GMI became negative in 8 of the 15 patients; 3 of these 8 patients (37.5%) were alive 90 days after the diagnosis of fusariosis compared with 2 of 7 (29%) who did not normalize GMI (p = 1.0). GMI is frequently positive in invasive fusariosis, and becomes positive before diagnosis in most patients. These findings may have important implications for the choice of antifungal therapy in settings with high prevalence of invasive fusariosis.

15 July 2010 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
MMMalgorzata Mikulska
Malgorzata Mikulska
VBV. Del Bono
V. Del Bono
RPR. Prinapori
R. Prinapori
LBL. Boni
L. Boni
ARA.M. Raiola
A.M. Raiola
CVC. Viscoli
C. Viscoli

1 April 2007
Verified
Journal Article
Closed access
PCPaola Cappellano
Paola Cappellano
CVClaudio Viscoli
Claudio Viscoli
PBPaolo Bruzzi
Paolo Bruzzi
MLMaria Teresa Van Lint
Maria Teresa Van Lint
CPCarlos Alberto Pires Pereira
Carlos Alberto Pires Pereira
ABAndrea Bacigalupo
Andrea Bacigalupo

5 April 2013 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
LMLiana Carballo Menezes
Liana Carballo Menezes
TRTalita Trevizani Rocchetti
Talita Trevizani Rocchetti
KBKaren de Castro Bauab
Karen de Castro Bauab
PCPaola Cappellano
Paola Cappellano
MQMilene Gonçalves Quiles
Milene Gonçalves Quiles
APAntonio Carlos Campos Pignatari
Antonio Carlos Campos Pignatari
Background: Early identification of pathogens and antimicrobial resistance in bloodstream infections (BSIs) decreases morbidity and mortality, particularly in immunocompromised patients. The aim of the present study was to compare real-time polymerase chain reaction (PCR) with commercial kits for detection of 17 pathogens from blood culture (BC) and 10 antimicrobial resistance genes. Methods: A total of 160 BCs were taken from bone marrow transplant patients and screened with Gram-specific probes by multiplex real-time PCR and 17 genus-specific sequences using TaqMan probes and blaSHV, blaTEM, blaCTX, blaKPC, blaIMP, blaSPM, blaVIM, vanA, vanB, and mecA genes by SYBR Green. Results: Twenty-three of 33 samples identified by phenotypic testing were concordantly positive by BC and real-time PCR. Pathogen identification was discordant in 13 cases. In 12 of 15 coagulase-negative staphylococci, the mecA gene was detected and four Enterococcus spp. were positive for vanA. Two blaCTX and three blaSHV genes were found by quantitative PCR. The blaKPC and metallo-β-lactamase genes were not detected. Five fungal species were identified only by real-time PCR. Conclusions: Real-time PCR could be a valuable complementary tool in the management of BSI in bone marrow transplants patients, allowing identification of pathogens and antimicrobial resistance genes.